COMMUNIQUÉS West-GlobeNewswire

Tiny Health, Pioneer of the First At-Home Baby Gut Microbiome Test, Aims to Address the Pediatric Chronic Conditions Crisis
05/03/2024
$13M in total funding will advance gut health innovation and reduce chronic health conditions that affect nearly half of U.S. children AUSTIN, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Tiny Health , the first at-home [...]
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
05/03/2024
Webcast presentation to take place at 11:25am ET ROCKVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical [...]
LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarkable Growth and Patient Adoption
05/03/2024
Venice, FL, USA, March 05, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc (OTCMKTS: LVCE), a pioneering healthcare technology company providing health coaches with 24/7 support to seniors with diabetes and high blood pressure, [...]
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
05/03/2024
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered [...]
Visory Health Names Ronald McDonald House Charities® of St. Louis As Its First Charity Supporting Children Locally
05/03/2024
With offices in both Estero and St. Louis, the health tech company expands its contributions to include the Missouri location ST. LOUIS, March 05, 2024 (GLOBE NEWSWIRE) -- Visory Health , a women-led, patient-first [...]
Er-Kim Selected to Join the World Economic Forum’s New Champions Community
05/03/2024
ATHENS, Greece, March 05, 2024 (GLOBE NEWSWIRE) -- Er-Kim , a pharmaceutical company specializing in the commercialization of novel therapies in international markets, announced today it has been selected to join the [...]
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
05/03/2024
• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans • Candidate showed similar half-life to standard monoclonal antibodies and minimal [...]
Noom Earns Highest CDC Recognition for Diabetes Prevention Program
05/03/2024
The CDC Full Plus Recognition sets a new standard for digital health solutions providing metabolic health, chronic disease prevention, and weight loss solutions NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Noom , the [...]
Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference
05/03/2024
PALM BEACH GARDENS, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Accelus , a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced [...]
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
05/03/2024
Conference Call and Webcast Scheduled for March 14, 2024 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal
05/03/2024
Dr. Roizen to provide expertise on longevity and aging Research on aging involving Telomir’s lead product candidate focused on reversing age-related decline and the extension of human life BALTIMORE, March 05, 2024 ( [...]
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
05/03/2024
Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately 25 million eye care [...]
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
05/03/2024
BELTSVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
05/03/2024
CORAL GABLES, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
05/03/2024
Dr. Jay Wohlgemuth, former Chief Medical & Scientific Officer of Quest Diagnostics and Dr. Ray Tabibiazar, a seasoned industry executive, to lead collaboration Mainz Biomed’s Pivotal FDA PMA clinical trial ( [...]
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
05/03/2024
NXP800 preliminary data update expected this month from the Phase 1b study in platinum resistant, ARID1a mutated ovarian cancer, a program that has been granted Fast Track Designation by the FDA NXP800 Investigator- [...]
Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
05/03/2024
MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
05/03/2024
CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
05/03/2024
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a [...]

Pages